Immunic is trading at $8.04, up 5.58%, with the move appearing consistent with biotech-sector strength.
- No new Immunic-specific announcement was identified for October 28; the latest company news listed by Immunic is dated October 21.
- Supplied sector context reports XBI up 2.18%, amid positive clinical and regulatory news across the industry.
- Broader market indexes were little changed, making sector sentiment a stronger explanation than general market direction.